Regeneron (REGN) says it expects to be exempt from the Pharma tariffs that it hears are being announced today

Regeneron's potential exemption from the new Pharma tariffs indicates a favorable regulatory stance that could enhance its competitive position in the biotech sector.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

Pakistan to start a targeted fuel subsidy, according to reports; raises petrol prices to INR 458.40/litre and diesel prices to INR 523.23/litre

EU's Kallas says they must scale up EU's aspides naval mission; cannot afford to lose another critical trade route

Regeneron (REGN) says it expects to be exempt from the Pharma tariffs that it hears are being announced today

JPMorgan says there is a risk of prices above USD 150/bbl if strait of Hormuz flows remain impaired into mid-May

Ukraine President Zelensky says Ukraine can help partners to support security of the Strait of Hormuz

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Expects to announce an MFN agreement in the near future.
Context

This likely alleviates immediate cost pressures and strengthens investor sentiment, which may prompt upward adjustments in equity valuations for Regeneron and similar firms. Watch for further developments on the MFN agreement as that will clarify the longer-term implications for pricing and market dynamics.

Related headlines

The whole workspace, free to try.

Try it free